505-54-4 | Sigma-Aldrich

Monoclonal Anti-Catalase antibody produced in mouse (C0979)

monoclonal clone CAT-505,purified from hybridoma cell culture Product Number C0979 Product Description Monoclonal Anti-Catalase (mouse IgG1 isotype) is derived from the CAT-505 hybridoma produced

XP725 Antibody Number-Lot Number 071M4826

e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32

Tools and Tips for Analyzing Apoptosis: A Kit Selection Guide

Guide26 Product Name Cat . No . M .W . Size Price Puromycin, Dihydrochloride 540222 544 .4 25 mg 100 mg €54 €181 1-Pyrrolidinecarbodithioic Acid, Ammonium Salt 548000 164 .3 100 mg €44 Quercetin

Product Information Sheet - 10822221001

A laboratory manual, pp 505-506. 4 Rebase The Restriction Enzyme Database: http://rebase.neb.com � Ad2 SV40 � X174 M13mp7 pBR322 pBR328 pUC18 14 54 12 3 4 5 4 4 sigma-aldrich.com

Product Information Sheet - P6024

Inc., New York, NY. Vol.1:23. 54. Wehling, M. et.al. (1987). ACTA Endocrinologica 116:555-560. 55. Wehling, M. et.al. (1987). Amer. Jour. of Phys. 252:505-508. 56. Wehling, M. et.al. (1988

Nitrate Spectroquant Test Kits Method 2017

1.01842 500 Table 4: Spectroquant® Test Kits Absorbance Maxima Range nm 1. 14 76 4 1. 14 56 3 1. 09 71 3 1. 00 61 4

Tools and Tips for Analyzing Apoptosis

activity in cell lysates by cleavage of a caspase-1 specific substrate . (Ex at 400 nm and Em at 505 nm) can be measured using a fluorometer or a fluorescence microplate reader . 1 Kit Caspase

Nitrate Spectroquant Test Kits Equivalency Report 2017

M et ho ds 4 50 0- N O 3 ( E ) H ac h T N T 8 36 1. 14 76 4 1. 14 56 3

Biologics 28.1

and D’Amore, P.A. 1997. FASEB J. 11, 365; Gastl, G., et al. 1997. Oncology 54, 177 ; Uhr, J.W., et al. 1997. Nature Med. 3, 505. LLooookk ffoorr tthhiiss ssyymmbbooll iinn tthhee 22000022//0033

Protein Tyrosine Phosphatases- Potential Roles in Disease

Fuente-Garcia, M.A., et al., Blood, 9, 2800-2809 (1998). 53. Autschbach, F., et al., Tissue Antigens, 54, 485-498 (1999). 54. Palou, E., et al., Immunol. Lett., 57, 101-103 (1997). 55. Hundt, M. and Schmidt, R.E.

BRAND Katalog EN

28 100 1 260 321 38 327 38 250 2 335 321 48 327 48 500 5 365 321 54 327 54 1000 10 465 321 62 327 62 2000 20 505 321 64 327 64 Graduated cy l inders , ta l

JULABO Catalog 2011 en

EH, MA, ME 9 902 439 Bath tank 39 with drain 39 50 x 30 / 30 54 x 33 / 35 ED, EH, MA, ME Makrolon® bath tanks to +100 °C 9 900 505 Bath tank

User Guide - 3299

. (1973). Epidemiology of Acute Lower Respiratory Disease in Children. N. Engl. J. Med. 288: 498-505. 11. Parrott, R.H., et al. (1962). III. Myxoviruses: Parainfluenza. Am. J. Public Health. 52:

Celltransmissions Newsletter

757 (2002). 34. Lee, R., et al., Cell Signal, 14, 277-284 (2002). 35. Niiya, T., et al., FEBS Lett., 505, 136-140 (2001). 36. Le Jeune, I.R., et al., J. Biol. Chem., 277, 35980-35989 (2002). 37. Torras-Llort

Calbiochem Biologics 30.2

CORRECTIONS 11.10.04.indd Sec2:11CORRECTIONS 11.10.04.indd Sec2:11 11/10/04 12:11:54 PM11/10/04 12:11:54 PM 12 N S O O OCH3 N H HO O N SO2

Brochure: Purospher STAR HPLC and UHPLC Columns

Ethylbenzene; 4. Quinizarin; 5. Amitryptyline 0 2 4 6 8 10 12 14 16 18 20 Retention time [min] 0 5 10 15 20 25 30 35 Intensity [mV]

Analyzing Fatty Acids by Capillary Gas Chromatography

Laboratory, 20, 100-105 (1988). 2. Ackman, R.G., Lipids, 2, 502-505 (1967). 3. Woodford, F.P. and C.M. Van Gent, J. Lipid Res., 1, 188 (1960). 4. Miwa, T.K., K.L. Mikolajczak, F.R. Earle, and I.A. Wolf, Anal

Article: Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis

no- mogram for acute-on-chronic hepatitis B liver failure, J. Gastroenterol. Hepatol. 32 (2017) 497–505. [14] T. Horvatits, A. Drolz, K. Roedl, et al., Serum bile acids as marker for acute de- compensation

Diabetes and Obesity

www.merckbio.eu/literature Argentina Merck Quimica Argentina S.A.I.C. Tel: +54 11 4546 8100 +54 11 4546 8156 Fax: +54 11 4546 8175 E-mail: mveltri@merck.com.ar www.merck.com.ar Australia Merck Pty

Katalog neoLab

4-1189 ladies 36 4-1190 ladies 38 4-1191 ladies 40 4-1192 ladies 42 4-1193 ladies 44 4-1194 ladies 46 4-1195 men 48 4-1196 men 50

Bioreactor Systems for Bone Tissue Engineering

of pulsed electromagnetic fields on bone formation and bone loss during limb lengthening. Bone 18, 505, 1996. 137. Gossling, H.R., Bernstein, R.A., and Abbott, J. Treatment of ununited tibial fractures

Organic and Molecular Electronics

×10-16s-1) SBD-1 474 62±3 1.8 3.4 1.2±0.20 0.97 SBD-4 504 92±2 2.2 4.4 9.5±1.0 1.54 BSB-Cz 462 99±1 1.0 10 0.32±0.05 2.70 BSB-Me 505 92±3 1.0 9.1 0.78±0.10 2.66 BSB-OMe 530 90±1 1.2 7.2 0.90

XP725 Antibody List Lot 129K4831

006149.2 y n/d y 497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y 505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d 378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y 491

XP725 Antibody List Lot 129K4830

006149.2 y n/d y 497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y 505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d 378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y 491

XP725 Antibody List Lot 089K4791

006149.2 y n/d y 497 Neurofibromin N3662 4763 NF1 M NP_000258.1,NP_001035957.1 ,NP_001121619.1 y y y 505 NF-kB N8523 4790 NFKB1 M NP_001158884.1 y y n/d 378 IkBa I0505 4792 NFKBIA P NP_065390.1 y y y 491

Amplifluor® SNPs HT Genotyping System for Assay Development

2000. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nature Biotechnology 18:505. 6. Nebert, D. 1999. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical

Amplifluor® SNPs HT Genotyping System for FAM-SR

2000. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nature Biotechnology 18:505. 6. Nebert, D. 1999. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical

Amplifluor® SNPs HT Genotyping System for FAM-JOE

2000. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nature Biotechnology 18:505. 6. Nebert, D. 1999. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical

Katalog OHAUS

D32XW60BL-EU-M 60 kg 20 g 550 x 420 mm 80252950 505 D32XW150BL-EU 150 kg 20 g 550 x 420 mm 80252907 447 D32XW150BL-EU-M 150 kg 50 g 550 x 420 mm 80252951 505 D32XW150BX-EU 150 kg 20 g 650 x 500 mm 80252908

Chrombook (WEB-Version)

3. Ethylbenzene 4. Quinizarin 5. Amitriptyline 0 2 4 6 8 10 12 14 16 18 20 Retention time [min] 0 5 10 15 20 25 30 35 Intensity [mV] 1. 54